Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmazie is indexed in Web of Science (SCIE). Its Scopus CiteScore is 1.9, quartile Q3. Published by Avoxa – Mediengruppe Deutscher Apotheker GmbH.
Checked against the index lists dated .
ISSN 0031-7144Verify ISSN ↗3053-691XVerify ISSN ↗
Publisher: Avoxa – Mediengruppe Deutscher Apotheker GmbH
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 119 / 191 | 37th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1947–2025).
Pharmazie is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.9, which places it in quartile Q3 at the 37th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.231, quartile Q3, with an H-index of 77.
Pharmazie is published by Avoxa – Mediengruppe Deutscher Apotheker GmbH. Its print ISSN is 0031-7144 and its online ISSN is 3053-691X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmazie has an h-index of 51 and a 2-year mean of 0.41 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q3.
Pharmazie published 30 papers in 2025; its busiest recent year was 2018 with 140. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from Japan (26.3%), China (23.2%) and Germany (12.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Inactive — coverage ended 2025. 3 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.